CC
PFE icon

Cedar Capital’s Pfizer PFE Stock Holding History

Cedar Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,032
Closed -$732K – 145
2020
Q3 		$732K Buy
21,032
+7,687
+58% +$270K 0.24% 103
2020
Q2 		$414K Sell
13,345
-97
-0.7% -$3.29K 0.16% 121
2020
Q1 		$416K Sell
13,442
-5,691
-30% -$194K 0.2% 107
2019
Q4 		$711K Buy
19,133
+3,275
+21% +$117K 0.33% 102
2019
Q3 		$541K Buy
15,858
+1,004
+7% +$36.5K 0.25% 112
2019
Q2 		$611K Buy
14,854
+514
+4% +$20.4K 0.26% 99
2019
Q1 		$578K Sell
14,340
-548
-4% -$21.9K 0.25% 107
2018
Q4 		$617K Buy
14,888
+1,094
+8% +$45.4K 0.31% 85
2018
Q3 		$577K Buy
13,794
+895
+7% +$34.5K 0.22% 109
2018
Q2 		$444K Buy
12,899
+1,629
+14% +$55.7K 0.2% 101
2018
Q1 		$379K Buy
11,270
+1,431
+15% +$49.2K 0.18% 101
2017
Q4 		$338K Buy
9,839
+1,590
+19% +$54.2K 0.16% 92
2017
Q3 		$279K Sell
8,249
-554
-6% -$17.8K 0.13% 90
2017
Q2 		$281K Buy
8,803
+2,115
+32% +$66.7K 0.12% 75
2017
Q1 		$217K Buy
+6,688
New +$211K 0.09% 92

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cedar Capital's PFE Position: Q4 2020 in Review

Cedar Capital sold out of Pfizer (PFE) in Q4 2020, closing a stake of 21,032 shares — an estimated $732K sold.

Cedar Capital first reported a position in PFE in Q1 2017 and held it in 15 quarters. The position peaked at $732K in Q3 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Cedar Capital reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 21,032 Pfizer shares in Q4 2020, an estimated $732K.
  • Cedar Capital first reported a position in Pfizer in Q1 2017 and held it in 15 quarters.
  • Cedar Capital's Pfizer position peaked at $732K in Q3 2020.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.